276 related articles for article (PubMed ID: 19620627)
1. Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function.
Trageser D; Iacobucci I; Nahar R; Duy C; von Levetzow G; Klemm L; Park E; Schuh W; Gruber T; Herzog S; Kim YM; Hofmann WK; Li A; Storlazzi CT; Jäck HM; Groffen J; Martinelli G; Heisterkamp N; Jumaa H; Müschen M
J Exp Med; 2009 Aug; 206(8):1739-53. PubMed ID: 19620627
[TBL] [Abstract][Full Text] [Related]
2. BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.
Klein F; Feldhahn N; Herzog S; Sprangers M; Mooster JL; Jumaa H; Müschen M
Oncogene; 2006 Feb; 25(7):1118-24. PubMed ID: 16205638
[TBL] [Abstract][Full Text] [Related]
3. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1
Schjerven H; Ayongaba EF; Aghajanirefah A; McLaughlin J; Cheng D; Geng H; Boyd JR; Eggesbø LM; Lindeman I; Heath JL; Park E; Witte ON; Smale ST; Frietze S; Müschen M
J Exp Med; 2017 Mar; 214(3):793-814. PubMed ID: 28190001
[TBL] [Abstract][Full Text] [Related]
5. Dominant-negative IKAROS enhances IL-3-stimulated signaling in wild-type but not BCR-ABL1(+) mouse BA/F3 cells.
von Palffy S; Bulaeva E; Babovic S; Kannan N; Knapp DJ; Wei L; Eaves CJ; Beer PA
Exp Hematol; 2015 Jul; 43(7):514-23.e1-2. PubMed ID: 25951974
[TBL] [Abstract][Full Text] [Related]
6. Expression of spliced oncogenic Ikaros isoforms in Philadelphia-positive acute lymphoblastic leukemia patients treated with tyrosine kinase inhibitors: implications for a new mechanism of resistance.
Iacobucci I; Lonetti A; Messa F; Cilloni D; Arruga F; Ottaviani E; Paolini S; Papayannidis C; Piccaluga PP; Giannoulia P; Soverini S; Amabile M; Poerio A; Saglio G; Pane F; Berton G; Baruzzi A; Vitale A; Chiaretti S; Perini G; Foà R; Baccarani M; Martinelli G
Blood; 2008 Nov; 112(9):3847-55. PubMed ID: 18650450
[TBL] [Abstract][Full Text] [Related]
7. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R
J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.
Katerndahl CDS; Heltemes-Harris LM; Willette MJL; Henzler CM; Frietze S; Yang R; Schjerven H; Silverstein KAT; Ramsey LB; Hubbard G; Wells AD; Kuiper RP; Scheijen B; van Leeuwen FN; Müschen M; Kornblau SM; Farrar MA
Nat Immunol; 2017 Jun; 18(6):694-704. PubMed ID: 28369050
[TBL] [Abstract][Full Text] [Related]
9. Direct interaction of Ikaros and Foxp1 modulates expression of the G protein-coupled receptor G2A in B-lymphocytes and acute lymphoblastic leukemia.
Bond J; Domaschenz R; Roman-Trufero M; Sabbattini P; Ferreiros-Vidal I; Gerrard G; Asnafi V; Macintyre E; Merkenschlager M; Dillon N
Oncotarget; 2016 Oct; 7(40):65923-65936. PubMed ID: 27588474
[TBL] [Abstract][Full Text] [Related]
10. Illegitimate RAG-mediated recombination events are involved in IKZF1 Δ3-6 deletion in BCR-ABL1 lymphoblastic leukaemia.
Dong Y; Liu F; Wu C; Li S; Zhao X; Zhang P; Jiao J; Yu X; Ji Y; Zhang M
Clin Exp Immunol; 2016 Sep; 185(3):320-31. PubMed ID: 27198500
[TBL] [Abstract][Full Text] [Related]
11. Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia".
Palmi C; Lana T; Silvestri D; Savino A; Kronnie GT; Conter V; Basso G; Biondi A; Valsecchi MG; Cazzaniga G
Haematologica; 2013 Dec; 98(12):e164-5. PubMed ID: 24323991
[No Abstract] [Full Text] [Related]
12. Targeting of heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL.
Lin X; Zou X; Wang Z; Fang Q; Chen S; Huang J; Zhe N; Yu M; Zhang Y; Wang J
Oncotarget; 2016 Aug; 7(33):53679-53701. PubMed ID: 27447561
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development.
Ma S; Pathak S; Trinh L; Lu R
Blood; 2008 Feb; 111(3):1396-403. PubMed ID: 17971486
[TBL] [Abstract][Full Text] [Related]
14. Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome.
Witkowski MT; Hu Y; Roberts KG; Boer JM; McKenzie MD; Liu GJ; Le Grice OD; Tremblay CS; Ghisi M; Willson TA; Horstmann MA; Aifantis I; Cimmino L; Frietze S; den Boer ML; Mullighan CG; Smyth GK; Dickins RA
J Exp Med; 2017 Mar; 214(3):773-791. PubMed ID: 28190000
[TBL] [Abstract][Full Text] [Related]
15. IK6 isoform with associated cytogenetic and molecular abnormalities in Chinese patients with Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
Yao L; Cen J; Chen S; Shen H; Chen Y; He J; Chen Z
Leuk Lymphoma; 2013 Aug; 54(8):1626-32. PubMed ID: 23150929
[TBL] [Abstract][Full Text] [Related]
16. Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia.
Qazi S; Uckun FM
Haematologica; 2013 Dec; 98(12):e151-2. PubMed ID: 24323986
[No Abstract] [Full Text] [Related]
17. Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia.
Churchman ML; Mullighan CG
Exp Hematol; 2017 Feb; 46():1-8. PubMed ID: 27865806
[TBL] [Abstract][Full Text] [Related]
18. SHP2 is required for BCR-ABL1-induced hematologic neoplasia.
Gu S; Sayad A; Chan G; Yang W; Lu Z; Virtanen C; Van Etten RA; Neel BG
Leukemia; 2018 Jan; 32(1):203-213. PubMed ID: 28804122
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.
Wang H; Song C; Ding Y; Pan X; Ge Z; Tan BH; Gowda C; Sachdev M; Muthusami S; Ouyang H; Lai L; Francis OL; Morris CL; Abdel-Azim H; Dorsam G; Xiang M; Payne KJ; Dovat S
J Biol Chem; 2016 Feb; 291(8):4004-18. PubMed ID: 26655717
[TBL] [Abstract][Full Text] [Related]
20. Expression of dominant-negative Ikaros isoforms and associated genetic alterations in Chinese adult patients with leukemia.
Liu P; Lin Z; Qian S; Qiao C; Qiu H; Wu Y; Li J; Ge Z
Ann Hematol; 2012 Jul; 91(7):1039-49. PubMed ID: 22323189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
